Show simple item record

dc.contributor.authorShebl, Nada Atef
dc.contributor.authorFranklin, Bryony Dean
dc.contributor.authorBarber, Nick
dc.identifier.citationShebl , N A , Franklin , B D & Barber , N 2007 , ' Clinical decision support systems and antibiotic use ' , Pharmacy World and Science , vol. 29 , no. 4 , pp. 342-349 .
dc.identifier.otherPURE: 1051739
dc.identifier.otherPURE UUID: d7d632eb-e652-4c93-a778-ad62cc2fdcef
dc.identifier.otherWOS: 000248577200002
dc.identifier.otherScopus: 34547610502
dc.description.abstractAim To review and appraise randomised controlled trials (RCT) and 'before and after' studies published on clinical decision support systems (CDSS) used to support the use of antibiotics. Methods A literature search. was carried out in October 2006 using MEDLINE including Medical Subject Heading (MeSH) terms (1966-2006), EMBASE (Excerpta Medica, 1980-2006) and International Pharmaceutical Abstracts (IPA, 1970-2006) using the combinations of the following terms: (Decision support systems) or (CDSS) AND (antibiotics) or (anti-infectives) or (antibacterials) or (antimicrobials). Only English language papers were selected. Editorials, letters and case reports/series were excluded. The reference sections of all retrieved articles were also searched for any further relevant articles. Results Forty articles were identified. Five RCT and six 'before and after' studies were retrieved. In the RCTs, three studies used computer-based CDSS, one paper-based CDSS and one a combination of both. Two studies were conducted in primary care and three within secondary care. The primary outcomes for each study were different and only three studies were significant in the favour of the use of CDSS. 'Before and after' studies were used where RCT were Dot feasible. One 'before and after' study was excluded because it did not include any control group. The remaining five included historical control groups and evaluated the use of computer-based CDSS within secondary care. Their primary outcomes also varied but all concluded significant, benefits of CDSS. Only three of ten studies were conducted outside the USA; one in Switzerland and two in Australia. Conclusion CDSS could be a powerful tool to improve clinical care and patient outcomes. It presents a promising future for optimising antibiotic use. However, it is difficult to generalise as most studies were conducted in the United States. Although RCT are the 'gold standard' in research, they may not be feasible to conduct. Realising that different study designs answer different questions would allow researchers to choose the most appropriate study design to evaluate CDSS in a specified setting.en
dc.relation.ispartofPharmacy World and Science
dc.titleClinical decision support systems and antibiotic useen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionHealth & Human Sciences Research Institute
dc.contributor.institutionDepartment of Pharmacy
dc.description.statusPeer reviewed
dc.relation.schoolSchool of Life and Medical Sciences

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record